COMMUNIQUÉS West-GlobeNewswire

ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States
13/05/2019
Investigational New Drug Application reviewed and accepted Enrollment of US patients expected to begin in Q3 2019 Clinical trial authorizations now obtained in all twelve participating countries LYON, France and [...]
ERYTECH annonce l'autorisation de la FDA américaine pour lancer l'étude de phase 3 avec eryaspase dans le cancer du pancréas aux États-Unis
13/05/2019
Demande d’ Investigational New Drug (IND) examinée et acceptée Début du recrutement de patients aux États-Unis prévu pour le troisième trimestre 2019 Obtention de l'autorisation de mener l’étude clinique désormais dans [...]
SPINEWAY : Réduction du capital social de Spineway
13/05/2019
Réduction du capital social de Spineway Erratum, annule et remplace le communiqué de presse du 7 mai Par décisions en date du 15 avril 2019, le Conseil d’Administration agissant sur délégation de compétence votée par l’ [...]
Precision Therapeutics to Report First Quarter 2019 Financial Results and Provide Company Update on Wednesday, May 15, 2019
13/05/2019
Conference Call to be held May 15, 2019, at 4:30pm Eastern Time MINNEAPOLIS, May 13, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces that it will report [...]
Kiadis Pharma Notice of Annual General Meeting of Shareholders
13/05/2019
Amsterdam, The Netherlands, 13 May 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a clinical-stage biopharmaceutical company, today announces that its Annual [...]
N.M. Medical Cannabis First Quarter Patient Sales Up 16% Over 2018
13/05/2019
Enrollment gains dramatically outpace sales indicating illicit market activity, public health risks ALBUQUERQUE, N.M., May 13, 2019 (GLOBE NEWSWIRE) -- The New Mexico Medical Cannabis Program patient revenues from the [...]
Orion Corporation completed share acquisitions
13/05/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 13 MAY 2019 at 18.45 EEST Orion Corporation completed share acquisitions The share acquisitions announced by Orion Corporation on 25 April 2019 have been completed. The Company [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
13/05/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) reports the following transactions: 1. Details of the person discharging managerial responsibility / person closely associated a) Name Henrik Jacobi 2. Reason for the [...]
ORION CORPORATION: ACQUISITION OF OWN SHARES 13.05.2019
13/05/2019
Orion Corporation NOTIFICATION 13.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 13.05.2019 Date 13.05.2019 Exchange transaction Buy Share class ORNBV Amount 9,906 Average price/share 29.0034 EUR Highest [...]
Adamas to Present at Upcoming BAML Investor Conference
13/05/2019
EMERYVILLE, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, today [...]
BBS strengthens the Board of Directors with acclaimed biomaterials expert Dr. Ilkka Kangasniemi
13/05/2019
BBS strengthens the Board of Directors with acclaimed biomaterials expert Dr. Ilkka Kangasniemi BBS – Bioactive Bone Substitutes, an innovator in orthobiologics, today announced that the acclaimed Dr. Ilkka Kangasniemi [...]
Inspirotec Inc and Argonne National Laboratory Collaborate on Largest Study to Date of Airborne Allergens and Microbiome in Same Homes.
13/05/2019
CHICAGO, May 13, 2019 (GLOBE NEWSWIRE) -- Inspirotec Inc., is a rapidly growing Chicago-based company with its Exhale™ highly portable whole house allergen measuring system and remediation support services. Exhale™ is [...]
Coloplast share buy-back week 19/2019
13/05/2019
Announcement 13 May 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Ossur Hf : Össur hf. initiates a new share buyback program
13/05/2019
Announcement from Össur hf. No. 31/2019 Reykjavík, 13 May 2019 Össur hf. initiates a new share buyback program Össur hf. has decided to initiate a new share buyback program (the "Program") tomorrow, 14 May 2019, which [...]
Ossur Hf : Share buyback program completed
13/05/2019
Announcement from Össur hf. No. 30/2019 Reykjavík, 13 May 2019 Share buyback program completed On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the [...]
Correction: Resolutions of the Annual General Meeting 2019
13/05/2019
Correction: Resolutions of the Annual General Meeting This release is a correction to BBS-Bioactive Bone Substitutes´ Resolutions of the Annual General Meeting company release issued on the 5th April 2019 at 4:00 PM ( [...]
Transactions under Novozymes’ stock buyback program
13/05/2019
Please read the full announcement in the attached PDF Attachment 2019_12_Stock_Buybackprogram_EN
Quick Umbrellux DAO Test Reveals If That Reaction Is Really Histamine Intolerance And Not A Food Allergy
13/05/2019
ANN ARBOR, Mich., May 13, 2019 (GLOBE NEWSWIRE) -- Food Allergy Awareness Week is the perfect time to determine if you may be mislabeling your body’s reaction to certain foods. Umbrellux DAO offers a self-evaluation kit [...]
InMode Announces PRS Publication and Launch of Aviva Technology For The Women’s Health and Wellness Market
13/05/2019
New developments impact functional medicine and pelvic floor restoration for women LAKE FOREST, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- InMode Ltd., a leading global provider of innovative, energy-based solutions, [...]

Pages